Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proton Therapy | 7 | 2024 | 155 | 0.810 |
Why?
|
| Radiotherapy, Intensity-Modulated | 7 | 2019 | 101 | 0.600 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 7 | 2019 | 107 | 0.550 |
Why?
|
| Ovarian Neoplasms | 2 | 2025 | 420 | 0.330 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2024 | 356 | 0.310 |
Why?
|
| Lung Neoplasms | 5 | 2024 | 1545 | 0.280 |
Why?
|
| Cellular Senescence | 2 | 2026 | 216 | 0.250 |
Why?
|
| Karyopherins | 1 | 2026 | 35 | 0.240 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2025 | 25 | 0.230 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2026 | 160 | 0.220 |
Why?
|
| Alanine | 1 | 2025 | 160 | 0.220 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2024 | 3 | 0.210 |
Why?
|
| BRCA1 Protein | 1 | 2024 | 77 | 0.200 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2026 | 318 | 0.200 |
Why?
|
| Inflammation | 2 | 2026 | 1481 | 0.170 |
Why?
|
| Radiotherapy Dosage | 5 | 2019 | 216 | 0.150 |
Why?
|
| Movement | 2 | 2016 | 147 | 0.130 |
Why?
|
| Protons | 2 | 2014 | 94 | 0.130 |
Why?
|
| DNA-Binding Proteins | 1 | 2025 | 1936 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 2 | 2019 | 637 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2025 | 2403 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2019 | 2061 | 0.110 |
Why?
|
| Nucleotidyltransferases | 2 | 2026 | 47 | 0.110 |
Why?
|
| Algorithms | 2 | 2019 | 1669 | 0.090 |
Why?
|
| Immunity, Innate | 2 | 2026 | 405 | 0.090 |
Why?
|
| Mutation | 1 | 2025 | 6059 | 0.090 |
Why?
|
| Esophageal Neoplasms | 1 | 2016 | 384 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2024 | 4663 | 0.080 |
Why?
|
| Organs at Risk | 2 | 2019 | 48 | 0.070 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 1283 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2026 | 113 | 0.060 |
Why?
|
| BRCA2 Protein | 1 | 2024 | 54 | 0.050 |
Why?
|
| Glycosylation | 1 | 2024 | 126 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2026 | 556 | 0.050 |
Why?
|
| Animals | 4 | 2026 | 33731 | 0.050 |
Why?
|
| Mice | 3 | 2025 | 18199 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2024 | 134 | 0.050 |
Why?
|
| Chromatin | 1 | 2026 | 499 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2024 | 387 | 0.050 |
Why?
|
| Humans | 11 | 2026 | 130514 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2024 | 17649 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 459 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2024 | 761 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3733 | 0.030 |
Why?
|
| Radiometry | 1 | 2015 | 49 | 0.030 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2014 | 11 | 0.030 |
Why?
|
| Respiratory Mechanics | 1 | 2014 | 80 | 0.030 |
Why?
|
| Respiration | 1 | 2014 | 117 | 0.020 |
Why?
|
| Aged | 2 | 2024 | 20897 | 0.020 |
Why?
|
| Female | 3 | 2025 | 70546 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 28420 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 1416 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 10034 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 20877 | 0.010 |
Why?
|
| Male | 2 | 2017 | 64587 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 31115 | 0.010 |
Why?
|